Latest news

The latest news, insight and product developments from Bleepa

Bleepa wins two NHS contract awards

Two twelve-month contracts awarded to provide Bleepa across two NHS Trusts.

April 12, 2022

Bleepa TB screening pilot now live in Odisha

The impact of this technology means that TB screening can now be expanded to rural areas where digital imaging was difficult to deliver, enabling current TB screening services to reach more people.

March 31, 2022

Feedback’s interim results published

Feedback PLC, Bleepa's parent company, has announced its unaudited interim results for the six months to 30 November 2021.

February 10, 2022

Digitally connecting community diagnostic centres

Bleepa can help community diagnostic centres to connect digitally with other care providers for a better, faster service for patients.

January 25, 2022

Partnership with Amazon Web Services

We are thrilled to announce that we have partnered with Amazon Web Services (AWS) to establish and deliver cloud-based tuberculosis (TB) screening services to rural communities in India.

December 17, 2021

Work
Remotely

Review
Dynamically

Discuss
As a team

See Bleepa in Action

Feedback Medical Ltd
Health Foundry
Canterbury House,
1 Royal Street,
South Bank,
London SE1 7LL

+44 (0)20 3997 7634 sales@fbkmed.com

Bleepa® is a product of
Feedback Medical Ltd.
Feedback Medical Ltd is a company registered in England and Wales. Registered Number: 04025026. Registered Office: Health Foundry, Canterbury House, 1 Royal Street, London, England, SE1 7LL.

VAT number: GB76000119